Moses is a consummate data manager with over 25 years’ experience in the pharmaceutical industry. He has held multiple leadership positions in various global CROs (in Australia and US) and in a US biotechnology company working primarily in early phase studies. Throughout his career, Moses has worked in numerous therapeutic areas.

Moses is the founding Managing Director of Resolutum Global and the Director of Data Management.

Stephan is a trained biostatistician. He has worked in the pharmaceutical industry since 2005, and he has supported all phases of clinical trials from phase I through to global regulatory submissions in multiple therapeutic areas. He has held lead roles in a global pharmaceutical company and global contract research organizations and has a deep understanding of the biometrics activities and requirement in both environments. Stephan has a proven ability to work closely with different functional groups and to communicate technical information to clinical and non-clinical teams.

Johannes (Jan) joined Resolutum Global in August 2021 as the Director of Biostatistics and has 25 years of professional experience as a Senior Manager, Manager, Principal Biostatistician, Biostatistician, Project Manager, and Statistical Programmer.

Jan has extensive experience across a diverge range of indications. He has experience in handling complex and multi-country projects coupled with a strong educational background. Jan has strong leadership, communication, planning and problem-solving skills gained through managing a range of projects. He has worked closely with the different functional groups integral to the various stages of clinical development.

Riaan brings in-depth statistical programming experience with over 20 years’ experience in the pharmaceutical industry. Riaan’s extensive experience draws from working in lead roles in various companies including large multinational CROs and a global pharmaceutical company. He has supported clinical trials at all stages of development from phase I to global regulatory submissions in multiple therapeutic areas.

Stella Burger studied at Monash University, Melbourne and has 20+ years working in business development within Australia only and pan Australia clinical trials for both biotech and pharmaceutical companies. Stella previously worked at Syneos Health where she managed international clients conducting work in Australia as well as supporting local biotechs in the clinical and commercial planning and execution of studies.

Patrick is an experienced biostatistician with over 25 years’ experience across a range of industries. His experience spans statistical consulting, experimental design, mixed models, survey design and analysis, preparation and review of clinical trial protocols and CSRs as well as non-compartmental PK analysis.

Patrick also has statistical consulting and research experience across academia, government research programs and projects and large administrative data collections. He has managed large teams of multi-discipline and multi-country personnel and has spent time in Europe as head of Data Management, Biostatistics and Statistical programming for and Director of Biostatistics roles for CROs.

With 17 years of experience in health research, including 16 years specializing in pharmaceutical clinical regulatory writing and over 5 years of leadership in the Australia and New Zealand (ANZ) region, Reshma is an experienced medical writing professional who has led and mentored high-performing teams across Australia and New Zealand as well as supported clients worldwide across global CROs, pharmaceutical companies, and medical communication companies.

She is passionate about simplifying complexity and delivering excellence. Over the years, she has honed her skills in preparing a variety of regulatory documents, from clinical study protocols and CSRs to CTD clinical modules and briefing books, across all study phases and therapeutic areas like oncology, CAR T cell therapy, siRNA therapy, vaccines, and more. Her expertise spans strategic medical writing, project finance, resource allocation, and delivering high-quality documents that drive successful clinical trials and regulatory submissions.